Fresenius Medical Care – market leader behind NephroCare
Dedicated to providing the best possible quality of life for patients with chronic renal failure, Fresenius Medical Care, which belongs to the Fresenius Group and is a world leader in dialysis, offers a complete range of products and services to support renal replacement therapy. For more than 20 years, through continuous development and innovation it has pioneered new techniques and technologies, our dialysis products have set the highest standards for the treatment of chronic renal failure worldwide. For us it is a natural step to use our unique experience and knowledge and apply them directly where they are needed – in providing care to the IRCT patient. With more than 3,900 clinics in North America, Europe, Latin America, Asia-Pacific and Africa, providing dialysis treatment to around 330.
NephroCare
NephroCare is the Fresenius Medical Care Group’s service delivery platform. We provide our services in dialysis units in more than 30 countries in Europe, the Middle East, Africa and Latin America. NephroCare has an explicit commitment to excellence in care for kidney patients. Our efforts focus on three main elements:
It currently treats more than 100,000 patients in more than 980 dialysis clinics, providing around 13 million treatments per year in more than 30 countries. This enormous growth is the result of a massive and sustainable investment in clinics and cutting-edge technologies. The constant reinforcement of strict safety and quality standards is becoming increasingly important as we increase our size and capacity. Safety standards and quality standards must be implemented and continuously monitored in all clinics, in accordance with Fresenius Medical Care’s high quality standards. NephroCare has more than 29,000 employees committed to providing the highest possible quality of care. We are aware of our responsibility to train our employees,
With NephroCare, Fresenius Medical Care is responsible for supporting healthcare systems with innovative concepts in this area, as well as providing high-quality, sustainable and affordable care to the growing number of chronic kidney patients.